mRNA |
JQ-1:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
FTI-277 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.12 |
0.001 |
mRNA |
AZD6482 |
GDSC1000 |
pan-cancer |
AAC |
-0.11 |
0.001 |
mRNA |
I-BET151 |
CTRPv2 |
pan-cancer |
AAC |
0.1 |
0.001 |
mRNA |
pifithrin-mu |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.001 |
mRNA |
Erlotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.17 |
0.001 |
mRNA |
phenformin |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.002 |